Compass Therapeutics, Inc.
CMPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $198,807 | $198,162 | $529,086 | $199,298 |
| - Cash | $43,483 | $24,228 | $34,946 | $144,514 |
| + Debt | $6,634 | $1,733 | $2,935 | $4,037 |
| Enterprise Value | $161,958 | $175,667 | $497,075 | $58,821 |
| Revenue | $850 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $850 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$54,872 | -$48,473 | -$39,751 | -$80,187 |
| % Margin | -6,455.5% | – | – | – |
| Net Income | -$49,375 | -$42,494 | -$39,225 | -$82,181 |
| % Margin | -5,808.8% | – | – | – |
| EPS Diluted | -0.36 | -0.33 | -0.35 | -1.31 |
| % Growth | -9.1% | 5.7% | 73.3% | – |
| Operating Cash Flow | -$44,855 | -$40,618 | -$34,125 | -$19,666 |
| Capital Expenditures | -$44 | -$30 | -$212 | -$1,568 |
| Free Cash Flow | -$44,899 | -$40,648 | -$34,337 | -$21,234 |